| 編號 | 商品編號 | 商品名稱 | 作者 | 類別 | 使用課程名稱 |
| 1 | B5726 | OncoMed Pharmaceuticals: Novel Anti-Cancer Stem Cell Therapeutics | Larry Lasky | Entrepreneurship | NCCU Harvard Business Case Study Club( None ) |
| 2 | 9-218-094 | Celgene | Baker, Malcolm P.;McComb, Emily R. | Finance | NCCU Harvard Business Case Study Club( None ) |
| 3 | HEC116 | Cipla Global Ltd.: Generics versus Drug Discovery | Pai, V.S. | General management | NCCU Harvard Business Case Study Club( None ) |
| 4 | 9-505-038 | Product Team Cialis: Getting Ready to Market | Ofek, Elie | Marketing | NCCU Harvard Business Case Study Club( None ) |
| 5 | 9-698-010 | Eli Lilly and Co.: Drug Development Strategy (A) | Thomke, Stefan;Pospisil, Paul;Nimgade, Ashok | Operations management | NCCU Harvard Business Case Study Club( None ) |
| 6 | 9-114-033 | Novartis'' Sandoz: Between Generics and Pharma | Palepu, Krishna G.;Knoop, Carin-Isabel | Other | NCCU Harvard Business Case Study Club( None ) |
| 7 | CMR300 | Socially Responsible Pricing: Lessons from the Pricing of AIDS Drugs in Developing Countries | Vachani, Sushil;Smith, N. Craig | Other | NCCU Harvard Business Case Study Club( None ) |
| 8 | CMR688 | Responding to a Potentially Disruptive Technology: How Big Pharma Embraced Biotechnology | Julian Birkinshaw;Ivanka Visnjic; Simon Best | Other | NCCU Harvard Business Case Study Club( None ) |
| 9 | H04BBZ | How Health Care Changes When Algorithms Start Making Diagnoses | Andrew Burt,Samuel Volchenboum | Other | NCCU Harvard Business Case Study Club( None ) |
| 10 | IES109 | New Model for the Pharmaceutical Industry: The Institute for OneWorld Health | Mair, Johanna;Schoen, Oliver | Other | NCCU Harvard Business Case Study Club( None ) |
|